Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-02-21 @ 6:45 PM
Study NCT ID:
NCT01434303
Status:
COMPLETED
Last Update Posted:
2019-05-20
First Post:
2011-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-13
First Submit QC Date:
None
Study First Post Date:
2011-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-17
Last Update Post Date:
2019-05-20
Last Update Post Date Type:
ACTUAL